More of us
ian Wilmut, the scientist who created Dolly, the world's first mammal cloned from an adult cell has struck a million-dollar deal with a us company to work on human cloning. According to a report in the London Daily Telegraph , Wilmut had agreed to help develop techniques to clone a patient's own cells for transplant, which could provide treatment for a wide range of degenerative diseases.
The project is a collaboration between the Roslin Institute, near Edinburgh, where Dolly was cloned in 1997, and the Californian-based company Geron. Wilmut will receive 83,000 shares of Geron, each worth us $12.
The report said that the new research will have many applications including insulin-producing cells to treat diabetes, nerve cells for stroke, Parkinson's disease and Alzheimer's patients, muscle cells to treat heart attacks and liver cells for the treatment of hepatitis. Producing tissue and cells for transplant will require the cloning of early human embryos, Wilmut said.
Related Content
- First food: business of taste
- Order of the National Green Tribunal regarding soild waste management in Shillong city, Meghalaya., 24/03/2025
- Order of the Supreme Court in the matter of student suicides in higher educational institutions, 24/03/2025
- Order of the National Green Tribunal regarding ozone pollution across urban India, 21/03/2025
- Judgment of the National Green Tribunal regarding thousands of trees facing danger due to illegal mining, Rupnagar district, Punjab, 19/03/2025
- Judgment of the National Green Tribunal regarding violation of environmental norms by Ansal Landmark Township, Meerut, Uttar Pradesh, 19/03/2025